Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comment on "The economics of follow-on drug research and development: trends in entry rates and the timing of development".

× No keyword cloud information.

4 in total

1. The Orphan Drug Act: an engine of innovation? At what cost?

Authors: D D Rohde
Journal: Food Drug Law J Date: 2000 Impact factor: 0.619

2. The economics of follow-on drug research and development: trends in entry rates and the timing of development.

Authors: Joseph A DiMasi; Cherie Paquette
Journal: Pharmacoeconomics Date: 2004 Impact factor: 4.981

3. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.

Authors: Richard L Kravitz; Ronald M Epstein; Mitchell D Feldman; Carol E Franz; Rahman Azari; Michael S Wilkes; Ladson Hinton; Peter Franks
Journal: JAMA Date: 2005-04-27 Impact factor: 56.272

4. Are novel drugs more risky for patients than less novel drugs?

Authors: Mary K Olson
Journal: J Health Econ Date: 2004-11 Impact factor: 3.883

4 in total

3 in total

1. Competitive pricing within pharmaceutical classes: evidence on "follow-on" drugs in Germany 1993-2008.

Authors: Michael T Mueller; Alexander Frenzel
Journal: Eur J Health Econ Date: 2013-12-27

Review 2. Sustainable Financing of Innovative Therapies: A Review of Approaches.

Authors: Aidan Hollis
Journal: Pharmacoeconomics Date: 2016-10 Impact factor: 4.981

Review 3. Competitiveness in follow-on drug R&D: a race or imitation?

Authors: Joseph A DiMasi; Laura B Faden
Journal: Nat Rev Drug Discov Date: 2010-12-10 Impact factor: 84.694

3 in total